In our previous study, the Proseek Oncology II assay measurements for both CA125 and HE4 correlated with the clinical values or ELISA measurements in serum samples obtained from women with late-stage high-grade serous ovarian cancer [12]. Here, WFDC2 is linked to ovarian serous adenocarcinoma.